in Croatia. The early detection of these genes will aid in the prevention and in the achievement of adequate infection control by limiting the spread of these organisms.
Introduction
Acinetobacter spp. is an opportunistic pathogen that has demonstrated increasing relevance in nosocomial infections [1, 2] . It is often associated with pneumonia, septicaemia, urinary tract infections, wound infections and meningitis. Carbapenem-resistant strains have been reported worldwide. The first outbreak of carbapenem-resistant Acinetobacter isolates in Croatia was documented in Split University Hospital [3] . As subsequently demonstrated, the carbapenem resistance was mediated by the hyperproduction of OXA-51 due the presence of IS Aba1 upstream of the genes [4] . Subsequent studies of carbapenem resistance in Croatia have reported the isolation of OXA-23-, OXA-58-and OXA-72-producing strains in different hospital centres in this country [5] [6] [7] ; however, no metallo-β-lactamases (MBLs) have been described. Since 2014, screening for MBLs in all Acinetobacter spp. isolates using phenotypic methods and PCR has been implemented at the University Hospital Center Zagreb. The first MBL-positive isolate was identified in Acinetobacter guillouiae . 
NDM-1-Producing Acinetobacter guillouiae

Methods
The bacterial strain was isolated from the drain of a child hospitalized in a paediatric intensive care unit and identified as A. guillouiae using a MALDI TOF automated system.
The child was treated with meropenem and vancomycin prior to isolation of this strain.
Antimicrobial susceptibility to a wide range of antibiotics was determined using the disk diffusion, VITEK-2 automated system (bioMérieux, Marcy-l'Etoile, France) and broth microdilution and interpreted according to CLSI [8] . The strain was resistant to meropenem (minimum inhibitory concentration, MIC = 32 μg/ml), ceftazidime, cefotaxime, ceftriaxone, cefepime and sulbactam/ampicillin with MIC of >128 μg/ml, gentamicin (MIC = 8 μg/ml) and ciprofloxacin (MIC = 4 μg/ml), intermediately susceptible to piperacillin/tazobactam (MIC = 64 μg/ml) and imipenem (8 μg/ ml), and susceptible to amikacin (MIC = 2 μg/ml) and colistin (MIC = 0.25 μg/ml).
The Hodge test and combined disk test with EDTA were positive, which indicated that MBL was produced. The MICs of meropenem and imipenem were not reduced by cloxacillin, but a small reduction of two dilutions was observed following the addition of sodium chloride, which indicated that OXA-58 was produced. The combined disk test with clavulanic acid was negative, demonstrating the absence of extended-spectrum β-lactamases. PCR and sequencing of chromosomal DNA from boiled colonies revealed bla OXA-58 and bla NDM-1 genes. Plasmid was extracted with the QIAGEN Mini Kit (Inel, Zagreb, Croatia) and subjected to PCR with primers specific for the bla OXA-58 and bla NDM-1 gene, but yielded no product indicating chromosomal origin of the genes. The incompatibility group of the plasmids described in Acinetobacter baumannii was determined by multiplex PCR with six primer pairs covering 19 homology groups according to Bertini et al. [9] . Plasmid extraction did not yield any products in mulitiplex PCR for incompatibility groups described so far. The class 1 integron was amplified with primers CSU-F and CSU-R as described previously [10] . The bla NDM-1 gene was encoded in the class 1 integron. This is the first report of NDM-1 in Acinetobacter spp. in Croatia.
Results and Discussion
This is the first report of NDM-1 in Acinetobacter spp. in Croatia. Previous studies have demonstrated the presence of NDM-1 in A. baumannii in the Czech Republic in a patient who was repatriated from Egypt [11] , in civilians in Lebanon who were wounded during the Syrian war [12] , and in East Africa [13] , Iran [14] and Belgium [15] . Outbreaks associated with NDM-1-positive A. baumannii have been described in France [16] . In India, the coexistence of OXA-23 and NDM-1 has been reported [17] . In the present study, we described the coproduction of NDM-1 and OXA-58 β-lactamase. The presence of IS Aba 3 upstream of the bla OXA-58 gene promotes the gene expression and the level of carbapenem resistance, and it is important for the mobilization of the gene. NDM-1 is hydrolyzing virtually all β-lactams but the strain was intermediately susceptible to piperacillin/tazobactam and imipenem. The level of β-lactam resistance in MBL-positive strains depends on the expression of the bla MBL gene and it is possible that A. guillouiae has low level expression of the gene due to a low gene copy number or weak promotor, which results in a small amount of enzyme produced. OXA-58 and NDM-1 β-lactamases are usually plasmid-mediated [7, 18] , but our strain yielded no amplicon with plasmid extract indicating chromosomal origin of the β-lactamases. The bla NDM-1 gene did not spread to other more pathogenic species in the genus Acinetobacter.
Due to effective infection control measures, the strain did not spread to other patients or other hospital units. In addition, the strain was not imported from a country with an epidemic. NDM-1 was identified for the first time in a Klebsiella pneumoniae isolate in Croatia in 2008 [19] and later spread to the Enterobacteriaceae [18] . MBL-positive Acinetobacter spp. isolates are a source of deep concern due to their multidrug resistance pattern and ability to persist in the environment [16] . Early detection of these genes will help in prevention and adequate infection control by limiting the spread of these organisms [20] . Therapeutic options are often very limited particularly since colistin-resistant isolates of Acinetobacter spp. have recently emerged also in Croatia. Colistin combined with other antibiotics such as vancomycin or meropenem is recommended for the treatment of infections associated with such pandrug-resistant strains [21, 22] .
